跳至主要内容
临床试验/NCT02232269
NCT02232269已完成1 期

Phase 1 Study of the Hemodynamic and Pharmacokinetic Interactions Between Coffee and Felodipine

Lawson Health Research Institute1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
13
试验地点
1
主要终点
The effect of felodipine on coffee-mediated increases in peripheral and central blood pressure .

研究概览

简要总结

Coffee is a globally popular beverage. More than half of the United States population spends an estimated $ 40 billion on the purchase of coffee each year. Personal consumption habits can vary. For example, the frequency of ingestion ranged from 59% for every day to 8% for less than one day per week consumption in one survey. In the case of occasional consumption, coffee can markedly elevate blood pressure in normotensive and hypertensive individuals. This pressor effect can occur with a caffeine dose of 200 - 250 mg, which can be found 2 - 3 cups of coffee. A major active constituent in coffee is caffeine, which is the most widely used pharmacological substance in the world.

Drug therapy plays a major role in the management of hypertension. However, the interaction between coffee or caffeine and blood pressure lowering drugs has been assessed in only three clinical studies that were reported more than three decades ago.

We conducted a comprehensive interaction study involving a commonly ingested amount of a particular Colombian coffee and felodipine in healthy middle-aged men and women. Peripheral (brachial) and central (aortic) hemodynamics and caffeine and felodipine pharmacokinetics were evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy (normal physical exam, blood clinical chemistry)
  • willingly signs ethics approved informed consent form

排除标准

  • history of cardiac, renal, hepatic or gastrointestinal disease or substance abuse
  • significant illness within 2 weeks of starting study
  • history of allergy to felodipine , tablet ingredients or dihydropyridines
  • routinely taking prescription or OTC drugs or natural health products
  • received an investigational drug withing the previous 4 weeks
  • females who are pregnant or breast-feeding

研究组 & 干预措施

Water plus Felodipine

Placebo Comparator

Felodipine extended-release tablet ,10 mg, single dose, 8 hours

干预措施: Water (Other)

Water plus Felodipine

Placebo Comparator

Felodipine extended-release tablet ,10 mg, single dose, 8 hours

干预措施: Felodipine (Drug)

Black Coffee

Active Comparator

Black Coffee, 300 ml, 0 and 1 hour

干预措施: Black Coffee (Other)

Black Coffee plus Felodipine

Experimental

Black Coffee, 300 ml, 0 and 1 hour

Felodipine extended-release tablet ,10 mg, single dose, 8 hours

干预措施: Black Coffee (Other)

Black Coffee plus Felodipine

Experimental

Black Coffee, 300 ml, 0 and 1 hour

Felodipine extended-release tablet ,10 mg, single dose, 8 hours

干预措施: Felodipine (Drug)

Grapefruit Juice plus Felodipine

Active Comparator

Grapefruit Juice, 300 ml, 0 and 1 hour

Felodipine extended-release tablet ,10 mg, single dose, 8 hours

干预措施: Grapefruit Juice (Other)

Grapefruit Juice plus Felodipine

Active Comparator

Grapefruit Juice, 300 ml, 0 and 1 hour

Felodipine extended-release tablet ,10 mg, single dose, 8 hours

干预措施: Felodipine (Drug)

结局指标

主要结局

The effect of felodipine on coffee-mediated increases in peripheral and central blood pressure .

时间窗: Change from Baseline to 8 hours Post Dose

Peripheral (brachial systolic and diastolic blood pressure) and central (aortic systolic blood pressure) measurements were the mean of at least 3 readings after 5 minutes of sitting at rest. The respective instruments used were BpTRU™ Vital Signs Monitor (BpTRU Medical Devices, Coquitlam BC, Canada) and SphygmoCor® CP Pulse Wave Analysis System - Research (AtCor Medical, Inc., Itasca, IL USA).

次要结局

  • The effect of coffee on the oral pharmacokinetics of felodipine.(Change from Baseline to 8 hours Post Dose)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Bailey

Principal Investigator

Lawson Health Research Institute

研究点 (1)

Loading locations...

相似试验